KMD Biomarker Diagnostics Overview

  • Founded
  • 2013
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

KMD Biomarker Diagnostics General Information


Developer of a malignancy test kit designed to analyze metabolic profiles for early-detection of breast cancer. The company's diagnostics testing kit uses metabolomics and biomarker analytics to find the combination of metabolites produced by abnormal cells in a given sample of urine and sends signals detecting the presence of malignant cells, enabling physicians to detect breast cancer non-invasively, cost effectively and painlessly.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Angel backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Primary Office
  • 202 North 9th Street
  • Boise, ID 83702
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

KMD Biomarker Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business Completed Out of Business
1. Product Crowdfunding 01-Jan-2015 00.000 Completed Startup
To view KMD Biomarker Diagnostics’s complete valuation and funding history, request access »

KMD Biomarker Diagnostics Executive Team (3)

Name Title Board Seat Contact Info
Nick Kaludov Ph.D Co-Founder
Dejan Nenov Co-Founder & Chief Executive Officer
Martin Martinov Ph.D Co-Founder
To view KMD Biomarker Diagnostics’s complete executive team members history, request access »